Results 251 to 260 of about 44,802 (314)

Antiarrhythmics cure brain arrhythmia: The imperativeness of subthalamic ERG K+channels in parkinsonian discharges

open access: yesScience Advances, 2017
Antiarrhythmics and proarrhythmics targeting ERG K+ channels act oppositely to tune parkinsonian brain rhythms and motor behaviors. ERG K+ channels have long been known to play a crucial role in shaping cardiac action potentials and, thus, appropriate ...
Chen-Syuan Huang   +2 more
exaly   +3 more sources

Antiarrhythmics

open access: yesClinical Pharmacokinetics, 2007
Carl A Gruetter
exaly   +4 more sources

Antiarrhythmics

open access: yes, 2018
Antiarrhythmic drugs are the cornerstone of supraventricular and ventricular arrhythmias therapy. Despite the increasing interest in invasive and ablative approaches to treating many arrhythmias, such as atrial fibrillation and ventricular tachycardia ...
Mathew George, Lincy Joseph, Sujith K
core   +8 more sources

Antiarrhythmics

Reactions Weekly
Abstract Antiarrhythmics are divided into four main Vaughan-Williams classifications based on their primary actions on the myocardial cell action potential (AP). The different classes of drugs exert their action on different phastes of the cardiac AP. New drugs and actions have become available or are being researched, including class 0,
exaly   +4 more sources

Metabolism of Antiarrhythmics

Current Drug Metabolism, 2004
Antiarrhythmics are a group of drugs that manage the irregular electrical activity of the heart. Their use in the clinic is made difficult by their narrow therapeutic index. The disposition of antiarrhythmics is dependent on many factors, such as administration route, stereoselectivity in the first-pass effect, inhibition of enzymes, polymorphisms, etc.
Huy Riem, Ha, Ferenc, Follath
openaire   +2 more sources

Home - About - Disclaimer - Privacy